AI assistant
Sending…
Teva Pharmaceutical Industries Ltd. — Director's Dealing 2025
Nov 18, 2025
7082_dirs_2025-11-18_77419a78-a4bb-4bc4-9aa4-325a5ccb964b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK: 0000818686
Period of Report: 2025-11-14
Reporting Person: Fox Christine (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-14 | Ordinary Shares | S | 30000 | $25.1107 | Disposed | 28384 | Direct |
Footnotes
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.